Skip to content
← Full study record

NCT03894618 · OUTCOME

Maximum Tolerated Dose (MTD) of SL-279252

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas · Source last updated 2025-04-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
From Day 1 to Day 21 (Schedule 1) or Day 28 (Schedule 2)

What was measured

Number of participants with dose limiting toxicities (DLTs)

Analysis population: DLT evaluable population

Groups in this outcome

SL-279252 (0.0001 mg/kg S1)

0.0001 mg/kg of IV SL-279252 (Schedule 1)

SL-279252 (0.001 mg/kg S1)

0.001 mg/kg of IV SL-279252 (Schedule 1)

SL-279252 (0.003 mg/kg S1)

0.003 mg/kg of IV SL-279252 (Schedule 1)

SL-279252 (0.01 mg/kg S1)

0.01 mg/kg of IV SL-279252 (Schedule 1)

SL-279252 (0.03 mg/kg S1)

0.03 mg/kg of IV SL-279252 (Schedule 1)

SL-279252 (0.1 mg/kg S1)

0.1 mg/kg of IV SL-279252 (Schedule 1)

SL-279252 (0.3 mg/kg S1)

0.3 mg/kg of IV SL-279252 (Schedule 1)

SL-279252 (1.0 mg/kg S1)

1.0 mg/kg of IV SL-279252 (Schedule 1)

SL-279252 (3.0 mg/kg S1)

3.0 mg/kg of IV SL-279252 (Schedule 1)

SL-279252 (6.0 mg/kg S1)

6.0 mg/kg of IV SL-279252 (Schedule 1)

SL-279252 (12.0 mg/kg S1)

12.0 mg/kg of IV SL-279252 (Schedule 1)

SL-279252 (24.0 mg/kg S1)

24.0 mg/kg of IV SL-279252 (Schedule 1)

SL-279252 (0.3 mg/kg S2)

0.3 mg/kg of IV SL-279252 (Schedule 2)

SL-279252 (1.0 mg/kg S2)

1.0 mg/kg of IV SL-279252 (Schedule 2)

SL-279252 (3.0 mg/kg S2)

3.0 mg/kg of IV SL-279252 (Schedule 2)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
SL-279252 (0.0001 mg/kg S1)1
SL-279252 (0.001 mg/kg S1)1
SL-279252 (0.003 mg/kg S1)2
SL-279252 (0.01 mg/kg S1)1
SL-279252 (0.03 mg/kg S1)2
SL-279252 (0.1 mg/kg S1)3
SL-279252 (0.3 mg/kg S1)4
SL-279252 (1.0 mg/kg S1)3
SL-279252 (3.0 mg/kg S1)5
SL-279252 (6.0 mg/kg S1)3
SL-279252 (12.0 mg/kg S1)4
SL-279252 (24.0 mg/kg S1)2
SL-279252 (0.3 mg/kg S2)3
SL-279252 (1.0 mg/kg S2)6
SL-279252 (3.0 mg/kg S2)3

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
SL-279252 (0.0001 mg/kg S1)0Not reportedNot reportedNot reportedNot reported
SL-279252 (0.001 mg/kg S1)0Not reportedNot reportedNot reportedNot reported
SL-279252 (0.003 mg/kg S1)0Not reportedNot reportedNot reportedNot reported
SL-279252 (0.01 mg/kg S1)0Not reportedNot reportedNot reportedNot reported
SL-279252 (0.03 mg/kg S1)0Not reportedNot reportedNot reportedNot reported
SL-279252 (0.1 mg/kg S1)0Not reportedNot reportedNot reportedNot reported
SL-279252 (0.3 mg/kg S1)0Not reportedNot reportedNot reportedNot reported
SL-279252 (1.0 mg/kg S1)0Not reportedNot reportedNot reportedNot reported
SL-279252 (3.0 mg/kg S1)0Not reportedNot reportedNot reportedNot reported
SL-279252 (6.0 mg/kg S1)0Not reportedNot reportedNot reportedNot reported
SL-279252 (12.0 mg/kg S1)0Not reportedNot reportedNot reportedNot reported
SL-279252 (24.0 mg/kg S1)0Not reportedNot reportedNot reportedNot reported
SL-279252 (0.3 mg/kg S2)0Not reportedNot reportedNot reportedNot reported
SL-279252 (1.0 mg/kg S2)0Not reportedNot reportedNot reportedNot reported
SL-279252 (3.0 mg/kg S2)0Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        0
      2. group Id
        OG001
        value
        0
      3. group Id
        OG002
        value
        0
      4. group Id
        OG003
        value
        0
      5. group Id
        OG004
        value
        0
      6. group Id
        OG005
        value
        0
      7. group Id
        OG006
        value
        0
      8. group Id
        OG007
        value
        0
      9. group Id
        OG008
        value
        0
      10. group Id
        OG009
        value
        0
      11. group Id
        OG010
        value
        0
      12. group Id
        OG011
        value
        0
denoms
  1. counts
    1. group Id
      OG000
      value
      1
    2. group Id
      OG001
      value
      1
    3. group Id
      OG002
      value
      2
    4. group Id
      OG003
      value
      1
    5. group Id
      OG004
      value
      2
    6. group Id
      OG005
      value
      3
    7. group Id
      OG006
      value
      4
    8. group Id
      OG007
      value
      3
    9. group Id
      OG008
      value
      5
    10. group Id
      OG009
      value
      3
    11. group Id
      OG010
      value
      4
    12. group Id
      OG011
      value
      2
    units
    Participants
description
Number of participants with dose limiting toxicities (DLTs)
groups
  1. description
    0.0001 mg/kg of IV SL-279252 (Schedule 1)
    id
    OG000
    title
    SL-279252 (0.0001 mg/kg S1)
  2. description
    0.001 mg/kg of IV SL-279252 (Schedule 1)
    id
    OG001
    title
    SL-279252 (0.001 mg/kg S1)
  3. description
    0.003 mg/kg of IV SL-279252 (Schedule 1)
    id
    OG002
    title
    SL-279252 (0.003 mg/kg S1)
  4. description
    0.01 mg/kg of IV SL-279252 (Schedule 1)
    id
    OG003
    title
    SL-279252 (0.01 mg/kg S1)
  5. description
    0.03 mg/kg of IV SL-279252 (Schedule 1)
    id
    OG004
    title
    SL-279252 (0.03 mg/kg S1)
  6. description
    0.1 mg/kg of IV SL-279252 (Schedule 1)
    id
    OG005
    title
    SL-279252 (0.1 mg/kg S1)
  7. description
    0.3 mg/kg of IV SL-279252 (Schedule 1)
    id
    OG006
    title
    SL-279252 (0.3 mg/kg S1)
  8. description
    1.0 mg/kg of IV SL-279252 (Schedule 1)
    id
    OG007
    title
    SL-279252 (1.0 mg/kg S1)
  9. description
    3.0 mg/kg of IV SL-279252 (Schedule 1)
    id
    OG008
    title
    SL-279252 (3.0 mg/kg S1)
  10. description
    6.0 mg/kg of IV SL-279252 (Schedule 1)
    id
    OG009
    title
    SL-279252 (6.0 mg/kg S1)
  11. description
    12.0 mg/kg of IV SL-279252 (Schedule 1)
    id
    OG010
    title
    SL-279252 (12.0 mg/kg S1)
  12. description
    24.0 mg/kg of IV SL-279252 (Schedule 1)
    id
    OG011
    title
    SL-279252 (24.0 mg/kg S1)
param Type
COUNT_OF_PARTICIPANTS
population Description
DLT evaluable population
reporting Status
POSTED
time Frame
From Day 1 to Day 21 (Schedule 1) or Day 28 (Schedule 2)
title
Maximum Tolerated Dose (MTD) of SL-279252
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice